First Tracks Biotherapeutics (TRAX) — Defensive Interval Ratio
First Tracks Biotherapeutics (TRAX) has a Defensive Interval Ratio of 2646 days as of December 2024. Defensive assets of $262.29 Million (cash $-, short-term investments $262.29 Million, receivables $-) cover 2646 days of daily cash needs of $99.13K/day. Check TRAX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
First Tracks Biotherapeutics Defensive Interval Ratio (2023–2024)
This chart shows how First Tracks Biotherapeutics's Defensive Interval Ratio has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the ratio stands at 2646 days, meaning defensive assets of $262.29 Million can fund 2646 days of operations without new revenue. Also explore First Tracks Biotherapeutics (TRAX) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for First Tracks Biotherapeutics (2023–2024)
The table below presents the year-by-year Defensive Interval Ratio for First Tracks Biotherapeutics from 2023 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see TRAX company net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2646 days | $262.29 Million | $99.13K/day | $- | $262.29 Million | ▼ -4463 days |
| 2023 | 7109 days | $354.94 Million | $49.93K/day | $- | $354.94 Million | — |